This study highlights the relevance of considering not only COPD phenotypes but also COPD endotypes (expression levels of Ppargc1a and/or Dio2) in the research and development of better treatment approaches for COPD. This evidence concerns the gene PPARGC1A and chronic obstructive pulmonary disease.